Bone Loss: Clinical Trials

11 trials for Bone Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 11Completed 1

Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Romosozumab in Women With Chronic SCI
Romosozumab, Alendronate - Osteoporosis, Bone Loss
Phase 2CompletedNorthwestern University122021-03-012025-09-24
Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
Zoledronic Acid, Placebo - Bone Loss, Muscle Atrophy
Phase 2CompletedStinus Gadegaard Hansen592021-02-202026-06-01
Healthy Body, Healthy Bones After Bariatric Surgery Trial
Zoledronic Acid 5 mg/Bag 100 ml Inj, Placebos - Bariatric Surgery Candidate, Bone Loss
Phase 1 / Phase 2CompletedUniversity of Nebraska102020-09-012024-09-24
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Zoledronic acid, Placebo - Spinal Cord Injury, Acute Spinal Cord Injury
Phase 2CompletedNorthwestern University602015-02-012025-12-02
Bone Mass and Strength After Kidney Transplantation
Vitamin D3, Calcitriol, Placebo - End Stage Renal Disease, Kidney Transplantation
Phase 2CompletedColumbia University612014-08-182025-03-07
Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
Alendronate, Calcium, Vitamin D - Spinal Cord Injury, Bone Loss
Phase 2CompletedNorthwestern University172014-04-012023-03-30
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Teriparatide, Vibration - Spinal Cord Injury, Bone Loss
Phase 2CompletedNorthwestern University252013-01-012023-05-10
Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
Zoledronic acid - HIV Infection, Bone Loss
Phase 2CompletedEmory University632011-01-012018-06-26
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
Teriparatide, vibration - Spinal Cord Injury, Bone Loss
Phase 2CompletedThomas J. Schnitzer602010-10-012025-12-02
The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
Lasofoxifene, Placebo - Bone Loss
Phase 2CompletedLigand Pharmaceuticals512004-09-012011-08-10
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
Zoledronic acid, Placebo - Bone Loss, Prostate Cancer
Phase 2CompletedMassachusetts General Hospital602003-09-012013-07-11

Narrower conditions

Bone Diseases, Metabolic (11)  ·  Osteoporosis (7)  ·  Spinal Cord Injuries (5)  ·  Bone Diseases (4)  ·  Spinal Cord Diseases (4)  ·  Central Nervous System Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Wounds and Injuries (3)  ·  Fractures, Bone (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Bone Resorption (1)  ·  HIV Infections (1)  ·  Hyperparathyroidism (1)

Broader conditions

Metabolic Diseases (11)  ·  Nutritional and Metabolic Diseases (11)  ·  Musculoskeletal Diseases (8)  ·  Bone Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Trauma, Nervous System (5)  ·  Signs and Symptoms (4)  ·  Nervous System Diseases (3)  ·  Urogenital Diseases (3)  ·  Wounds and Injuries (3)  ·  Central Nervous System Diseases (2)  ·  Genital Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Atrophy (1)  ·  Blood-Borne Infections (1)

Interventions

Zoledronic Acid (5)  ·  Alendronate (2)  ·  Cholecalciferol (2)  ·  Teriparatide (2)  ·  Antacids (1)  ·  Calcitriol (1)  ·  Calcium (1)  ·  Calcium Carbonate (1)  ·  Diphosphonates (1)  ·  Lasofoxifene (1)  ·  Sodium Chloride (1)  ·  Vitamin D (1)  ·  romosozumab (1)

Sponsors

Northwestern University (4)  ·  Columbia University (1)  ·  Emory University (1)  ·  Ligand Pharmaceuticals (1)  ·  Massachusetts General Hospital (1)  ·  Stinus Gadegaard Hansen (1)  ·  Thomas J. Schnitzer (1)  ·  University of Nebraska (1)

Countries

United States (9)  ·  Denmark (1)  ·  United Kingdom (1)

Top investigators

Thomas J Schnitzer, MD, PhD (4)  ·  Igho Ofotokun, MD, MSc (1)  ·  Laura D Bilek, PT, PhD (1)  ·  Matthew Smith, MD (1)  ·  Mervyn N Weitzmann, PhD (1)  ·  Thomas J Schnizter, MD, PhD (1)  ·  Thomas Nickolas, MD, MS (1)

Results publications

PMID 30334093, PMID 27193748, PMID 31621838, PMID 34278611, PMID 34887285, PMID 36209245, PMID 41177144